Overactivity within the cRAS axis is associated with downregulation of the counter-regulatory rRAS pathways, including reduced ACE-2/Ang-(1–7)/MasR signaling and dysregulated ang-III/AT4R signaling in AD (11–13). This evidence concerns the gene ACE2 and Alzheimer disease.